FDA Inspection 1203958 — Sun Pharmaceutical Industries Limited
The FDA completed an inspection of Sun Pharmaceutical Industries Limited on Mar 17, 2023 in New Delhi. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 17, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- New Delhi (India)
Additional Details
Clinical BA/BE